cl 246738 has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickinson, A; Halcrow, P; Hales, J; Harris, AL; Lawrence, GF; Lennard, TW; McDonald, M; Shenton, BK; Taylor, RM; Wolstencroft, R | 1 |
1 other study(ies) available for cl 246738 and Adenocarcinoma
Article | Year |
---|---|
A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738).
Topics: Acridines; Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged | 1989 |